发明名称 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF
摘要 <p>A medicine containing as the active ingredient a novel carboxylic acid derivative useful as an insulin resistance ameliorant. The carboxylic acid derivative is represented by the following general formula (I). Also provided are a salt or ester of the derivative and a hydrate of either. In the formula (I), R1 represents carboxyl, alkyl, alkoxy, etc.; L and T each represents a single bond, alkylene, alkynylene, etc.; M represents alkylene, etc.; W represents carboxyl; X represents oxygen, -NRX1CQ1O-, -OCQ1NRX1- , - CQ1NRX1O- (wherein Q1represents oxygen, etc. and RX1represents hydrogen, alkyl, etc.), etc.; and Y and Z each represents an optionally substituted 5- to 14- membered aromatic group, etc. [No Figure]</p>
申请公布号 SG161743(A1) 申请公布日期 2010.06.29
申请号 SG20060080477 申请日期 2002.04.18
申请人 EISAI R & D MANAGEMENT CO., LTD. 发明人 MATSUURA, FUMIYOSHI;EMORI, EITA;SHINODA, MASANOBU;CLARK, RICHARD;KASAI, SHUNJI;YOSHITOMI, HIDEKI;YAMAZAKI, KAZUTO;INOUE, TAKASHI;MIYASHITA, SADAKAZU;HIHARA, TARO;HARADA, HITOSHI;OHASHI, KAYA
分类号 C07C59/64;A61P1/00;A61P1/04;A61P1/18;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P19/10;A61P25/28;A61P29/00;A61P35/00;A61P37/02;C07C59/58;C07C59/68;C07C59/72;C07C233/25;C07C235/24;C07C251/48;C07C251/52;C07C251/54;C07C255/37;C07C255/54;C07C259/10;C07C271/14;C07C271/16;C07C271/22;C07C271/28;C07C271/58;C07C309/73;C07C309/75;C07C311/19;C07C317/18;C07C317/22;C07C323/20;C07D209/08;C07D209/18;C07D209/24;C07D213/30;C07D213/65;C07D213/68;C07D213/73;C07D213/75;C07D215/14;C07D215/18;C07D215/26;C07D235/06;C07D235/12;C07D277/56;C07D295/096;C07D295/192;C07D307/79;C07D317/54;C07D413/12;C07D417/12;(IPC1-7):C07C59/64;C07C59/66;C07C59/90;C07C251/50;C07C311/17 主分类号 C07C59/64
代理机构 代理人
主权项
地址